// App-Quantinova.ai

OC11.03 : Prospective validation of IOTA methods in the differentiation between benign and malignant adnexal masses

Researchers

Presenter

  • W. Froyman

Principal Investigators

  • B. De Cock

  • L. Wynants

  • A.C. Testa

  • E. Domali

  • P. Sladkevicius

  • L. Savelli

  • D. Franchi

  • E. Epstein

  • C. Van Holsbeke

  • R. Fruscio

  • M. Blanco

  • J. Alczar

  • S. Guerriero

  • A. Rossi

  • A. Czekierdowski

  • V. Chiappa

  • F. Buonomo

  • M.J. Kudla

  • T. Bourne

  • L. Valentin

  • J.Y. Verbakel

  • B. Van Calster

  • D. Timmerman

Medical Centers

  • Urology, Department of Development and Regeneration, University Hospitals Leuven, Leuven, Belgium

  • Department of Obstetrics and Gynecology, University Hospital Leuven, Kuleuven, Belgium

  • Department of Radiation Oncology, Catholic University of the Sacred Heart, Rome, Italy

  • Oncology Unit, 2nd Department of Surgery, Areteion Hospital National and Kapodistrian University of Athens, Athens, Greece

  • Department of Obstetrics and Gynecology, Skåne University Hospital Malmö, Lund University, Malmö, Sweden

  • Obstetrics and Gynecology, Sant' Orsola‐Malpighi Hospital, University of Bologna, Bologna, Italy

  • Preventive Gynecology Unit, Division of Gynecology, European Institute of Oncology, Milan, Italy

  • Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden

  • Department of Women's and Children's Health Karolinska Institutet, Stockholm, Sweden.

  • Department of Obstetrics and Gynecology, Ziekenhuis Oost‐Limburg, Genk, Belgium

  • Clinic of Obstetrics and Gynecology, University of Milan‐Bicocca, San Gerardo Hospital, Monza, Italy

  • Department of Obstetrics and Gynecology, Ospedale Garibaldi, Catania, Italy

  • Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, School of Medicine, Pamplona, Spain

  • Department of Obstetrics and Gynecology, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy

  • Department of Obstetrics and Gynecology, University of Udine, Udine, Italy

  • First Department of Gynecological Oncology, Medical University of Lublin, Lublin, Poland

  • Gynecological Oncology, National Cancer Institute of Milan, Milan, Italy

  • Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy

  • Clinical Department of Oncological Gynecology, Medical University of Silesia, Katowice, Poland

  • Queen Charlottes' and Chelsea Hospital, Imperial College London, London, United Kingdom

  • Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom

Locations

  • Belgium

  • Italy

  • Greece

  • Sweden

  • Spain

  • Poland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Carbohydrate antigen 125

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved